Gene Therapy Market

Best Price Guarantee	Publisher	Published Date	SKU
from $3,475	Evolve Business Intelligence	April, 2025	EVBI19932053

Best Price Guarantee
Price	from $3,475
Publisher	Evolve Business Intelligence
Published Date	April, 2025
SKU	EVBI19932053

The Gene Therapy Market is projected to reach USD 29.74 billion by 2033, growing from USD 8.64 billion in 2023 at a robust compound annual growth rate (CAGR) of 19.1% over the period. Gene therapy represents an advanced medical strategy designed to treat or prevent genetic disorders, diseases, or acquired conditions by introducing, modifying, or replacing genetic material within an individual's cells. This innovative approach aims to correct defective genes by delivering therapeutic genes directly to targeted tissues or utilizing modified viruses as carriers. By tackling the underlying genetic causes at the molecular level, gene therapy offers the potential to cure conditions previously deemed incurable. However, as an evolving field, it requires thorough evaluation, ethical considerations, and careful long-term monitoring to ensure its safety and effectiveness for widespread use.

The latest research report by Evolve Business Intelligence explores the various factors influencing the global market. It includes an analysis of the current market size, forecasts for key segments and regions, and the driving forces behind market growth. The report examines the potential impacts of key trends on business strategies and provides a SWOT analysis of critical sectors for each major competitor and customer group. This valuable data highlights the conglomerates likely to impact the industry, crucial for any company planning to invest strategically over the next five years. These insights complement our initial quantitative study, aiding in new investments and strategic planning to mitigate threats in existing sectors.

Segments covered

By Therapy Type (Somatic, Germline)
By Vector Type (Non-Viral Vectors, Viral Vectors)
By Application (Cancer Diseases, Monogenic Diseases, Infectious Diseases, Cardiovascular Diseases, Others)

Key players

REGENXBIO Inc
Oxford BioMedica plc
Dimension Therapeutics Inc
Bristol-Myers Squibb Company
SANOFI
Applied Genetic Technologies Corporation
Hoffmann-La Roche Ltd
bluebird Bio Inc
Novartis AG
Taxus Cardium Pharmaceuticals Group Inc

CHAPTER 1. Executive Summary: CHAPTER 2. Scope of the Study; 2.1. Market Definition; 2.2. Market Scope & Segmentation; 2.2.1. Objective of Report; CHAPTER 3. Evolve BI Methodology; 3.1. Data Collection & Validation Approach; 3.2. Market Size Estimation and Forecast; CHAPTER 4. Exclusive Analysis; 4.1. Market Opportunity Score; 4.1.1. Therapy Type Segement – Market Opportunity Score; 4.1.2. Vector Type Segment – Market Opportunity Score; 4.1.3. Application Segment – Market Opportunity Score; 4.2. Key Market Influencing Indicators; CHAPTER 5. Market Insights and Trends; 5.1. Value Chain Analysis; 5.1.1. Raw Material; 5.1.2. Manufacturing Process; 5.1.3. Distribution Channel; 5.1.4. End User; 5.2. Porter’s Five Forces Analysis; 5.2.1. Bargaining Power of Buyers; 5.2.2. Bargaining Power of Suppliers; 5.2.3. Threat of New Entrant; 5.2.4. Threat of Substitute; 5.2.5. Industry Rivalry; 5.3. COVID-19 Impact and Post COVID Scenario on Gene Therapy Market; 5.3.1. Impact of COVID-19; 5.3.2. Government Support and Industry Revival Policies; 5.3.3. Measures Taken by Companies to Mitigate Negative Impact; 5.3.4. Post COVID Trend; CHAPTER 6. MArket Dynamics; 6.1. Introduction; 6.2. Drivers; 6.2.1. Driver 1; 6.2.2. Driver 2; 6.2.3. Driver 3; 6.3. Restraints; 6.3.1. Restraint 1; 6.3.2. Restraint 2; 6.4. Opportunity; 6.4.1. Opportunity 1; CHAPTER 7. Global Gene Therapy Market, By Therapy Type; 7.1. Introduction; 7.1.1. Somatic; 7.1.2. Germline; CHAPTER 8. Global Gene Therapy Market, By Vector Type; 8.1. Introduction; 8.1.1. Non-Viral Vectors; 8.1.2. Viral Vectors; CHAPTER 9. Global Gene Therapy Market, By Application; 9.1. Introduction; 9.1.1. Cancer Diseases; 9.1.2. Monogenic Diseases; 9.1.3. Infectious Diseases; 9.1.4. Cardiovascular Diseases; 9.1.5. Others; CHAPTER 10. Global Gene Therapy Market, By Region; 10.1. Introduction; 10.2. NORTH AMERICA; 10.2.1. North America: Market Size and Forecast, By Country, 2023 – 2033 ($ Million); 10.2.2. North America: Market Size and Forecast, By Therapy Type, 2023 – 2033 ($ Million); 10.2.3. North America: Market Size and Forecast, By Vector Type, 2023 – 2033 ($ Million); 10.2.4. North America: Market Size and Forecast, By Application, 2023 – 2033 ($ Million); 10.2.5. US; 10.2.5.1. US: Market Size and Forecast, By Therapy Type, 2023 – 2033 ($ Million); 10.2.5.2. US: Market Size and Forecast, By Vector Type, 2023 – 2033 ($ Million); 10.2.5.3. US: Market Size and Forecast, By Application, 2023 – 2033 ($ Million); 10.2.6. CANADA; 10.2.6.1. Canada: Market Size and Forecast, By Therapy Type, 2023 – 2033 ($ Million); 10.2.6.2. Canada: Market Size and Forecast, By Vector Type, 2023 – 2033 ($ Million); 10.2.6.3. Canada: Market Size and Forecast, By Application, 2023 – 2033 ($ Million); 10.2.7. MEXICO; 10.2.7.1. Mexico: Market Size and Forecast, By Therapy Type, 2023 – 2033 ($ Million); 10.2.7.2. Mexico: Market Size and Forecast, By Vector Type, 2023 – 2033 ($ Million); 10.2.7.3. Mexico: Market Size and Forecast, By Application, 2023 – 2033 ($ Million); 10.3. Europe; 10.3.1. Europe: Market Size and Forecast, By Country, 2023 – 2033 ($ Million); 10.3.2. Europe: Market Size and Forecast, By Therapy Type, 2023 – 2033 ($ Million); 10.3.3. Europe: Market Size and Forecast, By Vector Type, 2023 – 2033 ($ Million); 10.3.4. Europe: Market Size and Forecast, By Application, 2023 – 2033 ($ Million); 10.3.5. U.K.; 10.3.5.1. U.K.: Market Size and Forecast, By Therapy Type, 2023 – 2033 ($ Million); 10.3.5.2. U.K.: Market Size and Forecast, By Vector Type, 2023 – 2033 ($ Million); 10.3.5.3. U.K.: Market Size and Forecast, By Application, 2023 – 2033 ($ Million); 10.3.6. GERMANY; 10.3.6.1. Germany: Market Size and Forecast, By Therapy Type, 2023 – 2033 ($ Million); 10.3.6.2. Germany: Market Size and Forecast, By Vector Type, 2023 – 2033 ($ Million); 10.3.6.3. Germany: Market Size and Forecast, By Application, 2023 – 2033 ($ Million); 10.3.7. FRANCE; 10.3.7.1. France: Market Size and Forecast, By Therapy Type, 2023 – 2033 ($ Million); 10.3.7.2. France: Market Size and Forecast, By Vector Type, 2023 – 2033 ($ Million); 10.3.7.3. France: Market Size and Forecast, By Application, 2023 – 2033 ($ Million); 10.3.8. ITALY; 10.3.8.1. Italy: Market Size and Forecast, By Therapy Type, 2023 – 2033 ($ Million); 10.3.8.2. Italy: Market Size and Forecast, By Vector Type, 2023 – 2033 ($ Million); 10.3.8.3. Italy: Market Size and Forecast, By Application, 2023 – 2033 ($ Million); 10.3.9. SPAIN; 10.3.9.1. Spain: Market Size and Forecast, By Therapy Type, 2023 – 2033 ($ Million); 10.3.9.2. Spain: Market Size and Forecast, By Vector Type, 2023 – 2033 ($ Million); 10.3.9.3. Spain: Market Size and Forecast, By Application, 2023 – 2033 ($ Million); 10.3.10. BENELUX; 10.3.10.1. BeNeLux: Market Size and Forecast, By Therapy Type, 2023 – 2033 ($ Million); 10.3.10.2. BeNeLux: Market Size and Forecast, By Vector Type, 2023 – 2033 ($ Million); 10.3.10.3. BeNeLux: Market Size and Forecast, By Application, 2023 – 2033 ($ Million); 10.3.11. RUSSIA; 10.3.11.1. Russia: Market Size and Forecast, By Therapy Type, 2023 – 2033 ($ Million); 10.3.11.2. Russia: Market Size and Forecast, By Vector Type, 2023 – 2033 ($ Million); 10.3.11.3. Russia: Market Size and Forecast, By Application, 2023 – 2033 ($ Million); 10.3.12. REST OF EUROPE; 10.3.12.1. Rest of Europe: Market Size and Forecast, By Therapy Type, 2023 – 2033 ($ Million); 10.3.12.2. Rest of Europe: Market Size and Forecast, By Vector Type, 2023 – 2033 ($ Million); 10.3.12.3. Rest of Europe: Market Size and Forecast, By Application, 2023 – 2033 ($ Million); 10.4. Asia Pacific; 10.4.1. Asia Pacific: Market Size and Forecast, By Country, 2023 – 2033 ($ Million); 10.4.2. Asia Pacific: Market Size and Forecast, By Therapy Type, 2023 – 2033 ($ Million); 10.4.3. Asia Pacific: Market Size and Forecast, By Vector Type, 2023 – 2033 ($ Million); 10.4.4. Asia Pacific: Market Size and Forecast, By Application, 2023 – 2033 ($ Million); 10.4.5. CHINA; 10.4.5.1. China: Market Size and Forecast, By Therapy Type, 2023 – 2033 ($ Million); 10.4.5.2. China: Market Size and Forecast, By Vector Type, 2023 – 2033 ($ Million); 10.4.5.3. China: Market Size and Forecast, By Application, 2023 – 2033 ($ Million); 10.4.6. JAPAN; 10.4.6.1. Japan: Market Size and Forecast, By Therapy Type, 2023 – 2033 ($ Million); 10.4.6.2. Japan: Market Size and Forecast, By Vector Type, 2023 – 2033 ($ Million); 10.4.6.3. Japan: Market Size and Forecast, By Application, 2023 – 2033 ($ Million); 10.4.7. INDIA; 10.4.7.1. India: Market Size and Forecast, By Therapy Type, 2023 – 2033 ($ Million); 10.4.7.2. India: Market Size and Forecast, By Vector Type, 2023 – 2033 ($ Million); 10.4.7.3. India: Market Size and Forecast, By Application, 2023 – 2033 ($ Million); 10.4.8. SOUTH KOREA; 10.4.8.1. South Korea: Market Size and Forecast, By Therapy Type, 2023 – 2033 ($ Million); 10.4.8.2. South Korea: Market Size and Forecast, By Vector Type, 2023 – 2033 ($ Million); 10.4.8.3. South Korea: Market Size and Forecast, By Application, 2023 – 2033 ($ Million); 10.4.9. THAILAND; 10.4.9.1. Thailand: Market Size and Forecast, By Therapy Type, 2023 – 2033 ($ Million); 10.4.9.2. Thailand: Market Size and Forecast, By Vector Type, 2023 – 2033 ($ Million); 10.4.9.3. Thailand: Market Size and Forecast, By Application, 2023 – 2033 ($ Million); 10.4.10. INDONESIA; 10.4.10.1. Indonesia: Market Size and Forecast, By Therapy Type, 2023 – 2033 ($ Million); 10.4.10.2. Indonesia: Market Size and Forecast, By Vector Type, 2023 – 2033 ($ Million); 10.4.10.3. Indonesia: Market Size and Forecast, By Application, 2023 – 2033 ($ Million); 10.4.11. MALAYSIA; 10.4.11.1. Malaysia: Market Size and Forecast, By Therapy Type, 2023 – 2033 ($ Million); 10.4.11.2. Malaysia: Market Size and Forecast, By Vector Type, 2023 – 2033 ($ Million); 10.4.11.3. Malaysia: Market Size and Forecast, By Application, 2023 – 2033 ($ Million); 10.4.12. AUSTRALIA; 10.4.12.1. Australia: Market Size and Forecast, By Therapy Type, 2023 – 2033 ($ Million); 10.4.12.2. Australia: Market Size and Forecast, By Vector Type, 2023 – 2033 ($ Million); 10.4.12.3. Australia: Market Size and Forecast, By Application, 2023 – 2033 ($ Million); 10.4.13. REST FO ASIA PACIFIC; 10.4.13.1. Rest fo Asia Pacific: Market Size and Forecast, By Therapy Type, 2023 – 2033 ($ Million); 10.4.13.2. Rest fo Asia Pacific: Market Size and Forecast, By Vector Type, 2023 – 2033 ($ Million); 10.4.13.3. Rest fo Asia Pacific: Market Size and Forecast, By Application, 2023 – 2033 ($ Million); 10.5. South America; 10.5.1. South America: Market Size and Forecast, By Country, 2023 – 2033 ($ Million); 10.5.2. South America: Market Size and Forecast, By Therapy Type, 2023 – 2033 ($ Million); 10.5.3. South America: Market Size and Forecast, By Vector Type, 2023 – 2033 ($ Million); 10.5.4. South America: Market Size and Forecast, By Application, 2023 – 2033 ($ Million); 10.5.5. BRAZIL; 10.5.5.1. Brazil: Market Size and Forecast, By Therapy Type, 2023 – 2033 ($ Million); 10.5.5.2. Brazil: Market Size and Forecast, By Vector Type, 2023 – 2033 ($ Million); 10.5.5.3. Brazil: Market Size and Forecast, By Application, 2023 – 2033 ($ Million); 10.5.6. ARGENTINA; 10.5.6.1. Argentina: Market Size and Forecast, By Therapy Type, 2023 – 2033 ($ Million); 10.5.6.2. Argentina: Market Size and Forecast, By Vector Type, 2023 – 2033 ($ Million); 10.5.6.3. Argentina: Market Size and Forecast, By Application, 2023 – 2033 ($ Million); 10.5.7. REST OF SOUTH AMERICA; 10.5.7.1. Rest of South America: Market Size and Forecast, By Therapy Type, 2023 – 2033 ($ Million); 10.5.7.2. Rest of South America: Market Size and Forecast, By Vector Type, 2023 – 2033 ($ Million); 10.5.7.3. Rest of South America: Market Size and Forecast, By Application, 2023 – 2033 ($ Million); 10.6. Middle East & Africa; 10.6.1. Middle East & Africa: Market Size and Forecast, By Country, 2023 – 2033 ($ Million); 10.6.2. Middle East & Africa: Market Size and Forecast, By Therapy Type, 2023 – 2033 ($ Million); 10.6.3. Middle East & Africa: Market Size and Forecast, By Vector Type, 2023 – 2033 ($ Million); 10.6.4. Middle East & Africa: Market Size and Forecast, By Application, 2023 – 2033 ($ Million); 10.6.5. SAUDI ARABIA; 10.6.5.1. Saudi Arabia: Market Size and Forecast, By Therapy Type, 2023 – 2033 ($ Million); 10.6.5.2. Saudi Arabia: Market Size and Forecast, By Vector Type, 2023 – 2033 ($ Million); 10.6.5.3. Saudi Arabia: Market Size and Forecast, By Application, 2023 – 2033 ($ Million); 10.6.6. UAE; 10.6.6.1. UAE: Market Size and Forecast, By Therapy Type, 2023 – 2033 ($ Million); 10.6.6.2. UAE: Market Size and Forecast, By Vector Type, 2023 – 2033 ($ Million); 10.6.6.3. UAE: Market Size and Forecast, By Application, 2023 – 2033 ($ Million); 10.6.7. EGYPT; 10.6.7.1. Egypt: Market Size and Forecast, By Therapy Type, 2023 – 2033 ($ Million); 10.6.7.2. Egypt: Market Size and Forecast, By Vector Type, 2023 – 2033 ($ Million); 10.6.7.3. Egypt: Market Size and Forecast, By Application, 2023 – 2033 ($ Million); 10.6.8. SOUTH AFRICA; 10.6.8.1. South Africa: Market Size and Forecast, By Therapy Type, 2023 – 2033 ($ Million); 10.6.8.2. South Africa: Market Size and Forecast, By Vector Type, 2023 – 2033 ($ Million); 10.6.8.3. South Africa: Market Size and Forecast, By Application, 2023 – 2033 ($ Million); 10.6.9. REST OF MIDDLE EAST & AFRICA; 10.6.9.1. Rest of Middle East & Africa: Market Size and Forecast, By Therapy Type, 2023 – 2033 ($ Million); 10.6.9.2. Rest of Middle East & Africa: Market Size and Forecast, By Vector Type, 2023 – 2033 ($ Million); 10.6.9.3. Rest of Middle East & Africa: Market Size and Forecast, By Application, 2023 – 2033 ($ Million); CHAPTER 12. Competitive Landscape; 12.1. Competitior Benchmarking 2023; 12.2. Market Share Analysis; 12.3. Key Developments Analysis By Top 5 Companies; 12.4. Market Share Acquisition Strategies: Analysis of Key Approaches Employed by Top Players; CHAPTER 13. Company Profiles; 13.1. REGENXBIO Inc; 13.1.1. Business Overview; 13.1.2. Financial Analysis; 13.1.2.1. Business Segment Revenue, 2020, 2021, 2022, $ Million; 13.1.2.2. Geographic Revenue Mix, 2022 (% Share); 13.1.3. Product Portfolio; 13.1.4. Recent Development and Strategies Adopted; 13.1.5. SWOT Analysis; 13.2. Oxford BioMedica plc; 13.3. Dimension Therapeutics Inc; 13.4. Bristol-Myers Squibb Company; 13.5. SANOFI; 13.6. Applied Genetic Technologies Corporation.; 13.7. Hoffmann-La Roche Ltd; 13.8. bluebird Bio Inc; 13.9. Novartis AG; 13.10. Taxus Cardium Pharmaceuticals Group Inc